Comprehensive Therapy

, 25:507 | Cite as

Managing asthma in the allergic patient

  • Oren P. Schaefer
Original Article


Asthma is a chronic disease afflicting more than 12 million people in the United States alone. In many patients, environmental allergens trigger their asthma. Physicians can control the disease with modification of the environment and education of the patient in allergen avoidance.


Asthma Rhinitis Allergic Rhinitis Allergy Clin Immunol Cetirizine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Sporik R, Holgate ST, Platts-Mills TAE, Cogsell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood: a prospective study.N Engl J Med. 1990;323:502–507.PubMedGoogle Scholar
  2. 2.
    Gelber LE, Seltzer LH, Bouzoukis JK, Pollar SM, Chapman MD, Platts-Mills TAE. Sensitization and exposure to indoor allergens as risk factors for asthma among patients presenting to hospital.Am Rev Respir Dis. 1993;147:573–578.PubMedGoogle Scholar
  3. 3.
    Ingram JM, Sporik R, Rose G, Honsinger R, Chapman MD, Platts-Mills TAE. Quantitative assessment of exposure to dog (Can f I) and cat (Fel d I) allergens: relation to sensitization and asthma among children living in Los Alamos, New Mexico.J Allergy Clin Immunol. 1995;96:449–456.PubMedCrossRefGoogle Scholar
  4. 4.
    Kang B. Study on cockroach antigen as a probable causative agent in bronchial asthma.J Allergy Clin Immunol. 1976;58:357–365.PubMedCrossRefGoogle Scholar
  5. 5.
    Halonen M, Stern DA, Wright AL, Taussig LM, Martinez FD. Alternaria as a major allergen for asthma in children raised in a desert environment.Am J Respir Crit Care Med. 1997;155:1356–1361.PubMedGoogle Scholar
  6. 6.
    Call RS, Smith TF, Morris E, Chapman MD, Platts-Mills TAE. Risk factors for asthma in inner city children.J Pediatr. 1992;121:862–868.PubMedCrossRefGoogle Scholar
  7. 7.
    Braman SS, Barrows AA, DeCotiis BA, et al. Airway hyper-responsiveness in allergic rhinitis: a risk factor for asthma.Chest. 1987;91:671–674.PubMedCrossRefGoogle Scholar
  8. 8.
    Rowe-Jones JM. The link between the nose and the lung, perennial rhinitis and asthma: is it the same disease?Allergy. 1997;52(suppl 36):20–28.PubMedGoogle Scholar
  9. 9.
    Pederson PA, Weeke ER. Asthma and allergic rhinitis in the same patients.Allergy. 1983;38:25–29.CrossRefGoogle Scholar
  10. 10.
    Greisner WA, Settipane RJ, Settipane GA. Co-existence of asthma and allergic rhinitis: a 23-year follow-up study of college students.Allergy Asthma Proc. 1998;19:185–188.PubMedCrossRefGoogle Scholar
  11. 11.
    Ramsdale EH, Morris MM, Roberts RS, Hargreave FE. Asymptomatic bronchial hyperresponsiveness in rhinitis.J Allergy Clin Immunol. 1987;79:358–363.CrossRefGoogle Scholar
  12. 12.
    Aubier M, Levy J, Clerici C, Neukirch F, Herman D. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis.Am Rev Respir Dis. 1992;146:122–126.PubMedGoogle Scholar
  13. 13.
    Mosbach H. House dust mite allergy.Allergy. 1985;40:81–91.CrossRefGoogle Scholar
  14. 14.
    Hoover GE, Platts-Mills TAE. What the pulmonologist needs to know about allergy.Clin Chest Med. 1995;16:603–620.PubMedGoogle Scholar
  15. 15.
    Platts-Mills TAE, Chapman, MD. Dust mites: immunology, allergic disease, and environmental control.J Allergy Clin Immunol. 1987;80:755–775.PubMedCrossRefGoogle Scholar
  16. 16.
    Murray AB, Ferguson AC, Morrison BJ. The seasonal variation of allergic respiratory symptoms induced by house dust mites.Ann Allergy. 1980;45:347–350.PubMedGoogle Scholar
  17. 17.
    Wood RA, Eggleston PA. Management of allergy to animal danders.Immunol Allergy Clin North Am. 1992;12:69–84.Google Scholar
  18. 18.
    Luczynska CM, Li Y, Chapman MD, Platts-Mills TAE. Airborne concentrations and particle size distribution of allergen derived from domestic cats (Felis domesticus): measurements using cascade impactor, liquid impinger, and a twosite monoclonal antibody assay for Fel d I.Am Rev Respir Dis. 1990;141:361–367.PubMedGoogle Scholar
  19. 19.
    Wood RA, Mudd KE, Eggleston PA. The distribution of cat and dust mite allergens on wall surfaces.J Allergy Clin Immunol. 1992;89:126–130.PubMedCrossRefGoogle Scholar
  20. 20.
    Rosenstreich DL, Eggleston P, Kattan M, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma.N Engl J Med. 1997;336:1356–1363.PubMedCrossRefGoogle Scholar
  21. 21.
    Nelson HS, Hirsch R, Ohma JL, et al. Recommendations for the use of residential air-cleaning devices in the treatment of allergic respiratory disease.J Allergy Clin Immunol. 1988;82:661–669.PubMedCrossRefGoogle Scholar
  22. 22.
    Expert Panel Report 2. Guidelines for the diagnosis and treatment of asthma. NIH publication 97-4051. April 1997.Google Scholar
  23. 23.
    Kohler CL, Davies SL, Bailey WC. How to implement an asthma education program.Clin Chest Med. 1995;16:557–566.PubMedGoogle Scholar
  24. 24.
    Barnes PJ, Pederson S, Busse WW. Efficacy and safety of inhaled corticosteroids: new developments.Am Rev Respir Crit Care Med. 1998;157:S1-S53.Google Scholar
  25. 25.
    Agertoft L, Pederson S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.Resp Med. 1994;88:373–381.CrossRefGoogle Scholar
  26. 26.
    Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel group controlled trial.J Allergy Clin Immunol. 1992;90:32–42.PubMedCrossRefGoogle Scholar
  27. 27.
    Grossman J. One airway, one disease.Chest. 1997;111:11S-16S.PubMedCrossRefGoogle Scholar
  28. 28.
    Findlay SR, Barden JM, Easley CB, Glass M. Effect of the oral leukotriene antagonist ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma.J Allergy Clin Immunol. 1992;89:1040–1045.PubMedCrossRefGoogle Scholar
  29. 29.
    Nathan RA, Glass M, Minkwitz MC. Inhaled ICI 204,219 blocks antigen induced bronchoconstriction in subjects with bronchial asthma.Chest. 1994;105:483–488.PubMedCrossRefGoogle Scholar
  30. 30.
    Hui KP, Taylor IK, Taylor GW, et al. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients.Thorax. 1991;46:184–189.PubMedCrossRefGoogle Scholar
  31. 31.
    Watson WTA, Becker AB, Simons FER. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: Effect on lower airway responsiveness.J Allergy Clin Immunol. 1993;91:97–101.PubMedCrossRefGoogle Scholar
  32. 32.
    Welsh PW, Strickler EW, Chu-Pin C, et al. Efficacy of beclomethasone nasal solution, flunisolide and cromolyn in relieving symptoms of ragweed allergy.Mayo Clin Proc. 1987;62:125–134.PubMedGoogle Scholar
  33. 33.
    Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma.J Allergy Clin Immunol. 1992;90:250–256.PubMedCrossRefGoogle Scholar
  34. 34.
    Corren J, Harris A, Aaronson D, et. al. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma.J Allergy Clin Immunol. 1997;100:781–788.PubMedCrossRefGoogle Scholar
  35. 35.
    Grant JA, Nicodemus CF, Findlay SR, et. al. Cetirizine in patients with seasonal allergic rhinitis and concomitant asthma: a prospective, randomized, placebo-controlled trial.J Allergy Clin Immunol. 1995;95:923–932.PubMedCrossRefGoogle Scholar
  36. 36.
    Bousquet J, Michel FB. Specific immunotherapy in asthma: is it effective?J Allergy Clin Immunol. 1994;94:1–11.PubMedCrossRefGoogle Scholar
  37. 37.
    Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials.Am J Respir Crit Care Med. 1995;151:969–974.PubMedGoogle Scholar
  38. 38.
    Creticos PS, Reed CE, Norman PS, et al. Regweed immunotherapy in adult asthma.N Engl J Med. 1996;334:501–506.PubMedCrossRefGoogle Scholar
  39. 39.
    Adkinson NF Jr, Eggleston PA, Eney D, et. al. A controlled trial of immunotherapy for asthma in allergic children.N Engl J Med. 1997;336:324–331.PubMedCrossRefGoogle Scholar
  40. 40.
    Tamir R, Levy I, Duer S, Pick AL. Immediate adverse reactions to immunotherapy in allergy.Allergy. 1992;47:260–263.PubMedCrossRefGoogle Scholar
  41. 41.
    Reid MJ, Lockey RF, Turkeltaub PC, Platts-Mills TAE. Survey of fatalities from immunotherapy and skin testing 1985–1989.J Allergy Clin Immunol. 1993;92:6–15.PubMedCrossRefGoogle Scholar
  42. 42.
    AAAI Board of Directors. Guidelines to minimize the risk from systemic reactions caused by immunotherapy with allergenic extracts.J Allergy Clin Immunol. 1994;93:811–812.CrossRefGoogle Scholar

Copyright information

© the American Society of Contemporary Medicine and Surgery 1999

Authors and Affiliations

  • Oren P. Schaefer
    • 1
  1. 1.Division of Pulmonary, Allergy & Critical Care MedicineUniversity of Massachusetts Memorial Health Care—University CampusWorcester

Personalised recommendations